About: http://data.cimple.eu/news-article/9c645824d6d229cb6e060bb2d28ad33f4f61e996b99b159452bb2adf     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Tokyo's benchmark Nikkei index closed down more than three percent Tuesday as tech shares were hit by selling pressure following a plunge in the Nasdaq on Wall Street. The Nikkei 225 index sank 3.08 percent, or 909.75 points, to 28,608.59, while the broader Topix index dropped 2.37 percent, or 46.35 points, to 1,905.92. Tokyo shares opened sharply lower and extended their losses in afternoon trade after the tech-rich Nasdaq dropped 2.6 percent Monday. "Stocks fell broadly but high-tech shares were hit hard," Shinichi Yamamoto, a broker at Okasan Securities, told AFP. "We don't need to be too pessimistic but trading is expected to remain cautious for now," Yamamoto said. Daiwa Securities chief technical analyst Eiji Kinouchi said: "Bargain-hunting is likely to emerge at this level of the Nikkei. Tokyo shares are likely to touch the bottom in a week or so and rebound moderately." Investors continued to focus on corporate results as Japan's earnings season reaches its peak, Kinouchi added. The dollar stood at 108.85 yen in Asian afternoon trade, compared with 108.77 yen in New York. Tech-related shares were among losers. Chip-testing equipment maker Advantest dropped 5.49 percent to 9,640 yen, and Tokyo Electron, a major producer of tools to build semiconductors, lost 4.11 percent to 48,000 yen. SoftBank Group, which has invested in some of Silicon Valley's hottest start-ups and tech ventures, plunged 6.50 percent to 9,508 yen. Nissan, which will release its annual earnings later in the day, fell 0.65 percent to 578.6 yen. Japan's top drugmaker Takeda Pharmaceutical gave up earlier gains and closed down 0.21 percent to 3,722 yen. The company has conducted a trial of Moderna's coronavirus vaccine in Japan and submitted the results to the government on Monday, confirming the jab's effectiveness and paving the way for its approval. The Japanese government, which has so far only approved the Pfizer jab, wants to approve the Moderna vaccine this month to boost its inoculation efforts. Takeda's rival Shionogi gained 1.19 percent to 5,866 yen after its president reportedly said it expects to provide a coronavirus vaccine within the year. It would be the first domestically produced vaccine in Japan. si/kaf/axn
schema:headline
  • Tokyo's Nikkei closes down more than 3% on tech sell-off
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software